About Medicus Pharma
Medicus Pharma is a company based in Toronto (Canada) founded in 2008.. Medicus Pharma has completed 1 acquisition, including Antev. Medicus Pharma offers products and services including Skin Cancer Treatment Regimen. Medicus Pharma operates in a competitive market with competitors including PPD, Cambrian BioPharma, H.U. Group Holdings, DM Clinical and IPHARMA, among others.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Medicus Pharma Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$11.02 M (USD), Post-IPO
May 03, 2024
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Medicus Pharma
Medicus Pharma is a publicly listed company on the NASDAQ with ticker symbol MDCX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Medicus Pharma
Medicus Pharma offers a comprehensive portfolio of products and services, including Skin Cancer Treatment Regimen. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive regimen for treating skin cancer via clinical programs.
Unlock access to complete
Unlock access to complete
Funding Insights of Medicus Pharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $11.0M
-
First Round
First Round
(03 May 2024)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Post-IPO - Medicus Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Medicus Pharma
Medicus Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Antev. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
GnRH antagonists for urology indications in humans & animals
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Medicus Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Medicus Pharma Comparisons
Competitors of Medicus Pharma
Medicus Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PPD, Cambrian BioPharma, H.U. Group Holdings, DM Clinical and IPHARMA, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CRO providing diversified clinical development services
|
|
| domain | founded_year | HQ Location |
Medicines and therapies are developed for healthcare applications.
|
|
| domain | founded_year | HQ Location |
Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.
|
|
| domain | founded_year | HQ Location |
Conducts Phase I-IV clinical trials connecting patients with physicians for medical research.
|
|
| domain | founded_year | HQ Location |
Serves as a contract research organization focused on drug clinical trials.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Medicus Pharma
Frequently Asked Questions about Medicus Pharma
When was Medicus Pharma founded?
Medicus Pharma was founded in 2008 and raised its 1st funding round 16 years after it was founded.
Where is Medicus Pharma located?
Medicus Pharma is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Who is the current CEO of Medicus Pharma?
Raza Bokhari is the current CEO of Medicus Pharma.
What does Medicus Pharma do?
Medicus Pharma Ltd. is a clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies. They are involved in biotechnology research and accelerate life sciences and bio-technology companies through FDA clinical trials.
Who are the top competitors of Medicus Pharma?
Medicus Pharma's top competitors include PPD, Cambrian BioPharma and H.U. Group Holdings.
What products or services does Medicus Pharma offer?
Medicus Pharma offers Skin Cancer Treatment Regimen.
Is Medicus Pharma publicly traded?
Yes, Medicus Pharma is publicly traded on NASDAQ under the ticker symbol MDCX.
How many acquisitions has Medicus Pharma made?
Medicus Pharma has made 1 acquisition, including Antev.
What is Medicus Pharma's ticker symbol?
The ticker symbol of Medicus Pharma is MDCX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.